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Abstract
Purpose 2,3-Oxidosqualene cyclase (OSC), an important en-
zyme of cholesterol biosynthesis, catalyzes the highly selec-
tive cyclization of 2,3-monoepoxysqualene to lanosterol. In-
termittent hypoxia (IH) is a hallmark feature in obstructive
sleep apnea (OSA) which is increasingly recognized as an
independent risk factor for liver injury. The aim of this study
was to determine the effect of IH on OSC expression and
evaluate the role of OSC in the IH-induced apoptosis in he-
patic cell line human liver cell (HL-02).
Methods HL-02 cells were exposed to normoxia or IH. Cell
Counting Kit-8 (CCK-8) assay was used to value cell prolif-
eration, and flow cytometry was used to determine cell apo-
ptosis. The expression of OSC messenger RNA (mRNA) was
evaluated by quantitative real-time PCR, and the expression of
OSC protein was determined by Western blot. To further in-
vestigate the function of OSC in IH-induced apoptosis,
oxidosqualene cyclase-enhanced green fluorescence protein
(OSC-EGFP) plasmid was constructed to over-express OSC
protein. Triglyceride content in HL-02 cells was analyzed by
oil red staining or Triglyceride Quantification Kit.
Results We found that IH inhibited HL-02 cell proliferation
and accelerated cell apoptosis. IH decreased OSC expression,
and over-expression of OSC could protect HL-02 cells against
the IH-induced hepatic cell injury. Moreover, over-expression
of OSC could attenuate IH-induced cellular triglyceride
accumulation.
Conclusions These findings suggest that OSC are involved in
IH-induced hepatic cell injury. These results may contribute to
the further understanding of the mechanism underlying the
liver injury in OSA patients.
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Introduction
Obstructive sleep apnea (OSA) is caused by recurrent closure
of the upper airway during sleep, which leads to repetitive
intermittent hypoxia (IH) [1]. OSA is a common disorder,
present in 2 % of women and 4 % of men in the population
[2, 3]. Obesity is a major risk factor for OSA, and prevalence
of OSA exceeds 50 % in obese men [4, 5]. OSA has been
associated with an increased risk of hypertension, type 2 dia-
betes, dyslipidemia, and atherosclerosis, independent of un-
derlying obesity [6–9]. Moreover, accumulating evidence
showed that OSA is associatedwith elevation in liver enzymes
and biopsy evidence of liver injury. The severity of liver injury
in patients with OSA directly correlates with the severity of
the hypoxic insult [10–13].
Although OSA has been proposed to be a potential risk
factor of liver injury, the underlying mechanism is still
unobvious. In the study conducted by Li J et al., after the
leptin-deficient obese (ob/ob) mice were exposed to IH during
the light phase (9 a.m.–9 p.m.) for 12 weeks, IH caused a 30%
increase in liver triglyceride and phospholipid, whereas liver
cholesterol content was unchanged. Gene expression analysis
showed that IH up-regulated sterol regulatory element-
binding protein (SREBP)-1, a master regulator of lipogenesis.
Expression of major genes of cholesterol biosynthesis,
SREBP-2 and 3-hydroxy-3-methylglutaryl-CoA reductase,
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was unchanged [14, 15]. In this study, we evaluated the impact
of IH on the expression of 2,3-oxidosqualene cyclase (OSC),
another important enzyme of cholesterol biosynthesis, in the
human hepatic cell line HL-02. Furthermore, we analyzed the
role of OSC in the hepatic injury caused by IH.
OSC is downstream of cholesterol biosynthesis. OSC cat-
a lyzes the h igh ly se lec t ive cyc l i za t ion of 2 ,3 -
monoepoxysqualene (MOS) to lanosterol, the first sterol to
be formed. OSC also catalyzes cyclization of 2,3;22,23-
diepoxysqualene (DOS), which itself is derived from MOS,
to 24(S),25-epoxylanosterol, the immediate precursor of
24(S),25-epoxycholesterol. Synthesis of 24(S),25-
epoxycholesterol is favored over cholesterol synthesis under
conditions of partial OSC inhibition [16–18]. Although many
studies revealed IH caused dyslipidemia, the impact of IH on
the expression of OSC and its role in the IH-induced hepatic
injury has not been reported. In the present study, we investi-
gated the effect of IH on the proliferation of HL-02 cells and
OSC expression. Moreover, we analyzed the role of OSC in
the IH-induced hepatic injury.
Materials and methods
Cell culture and intermittent hypoxia treatment
TheHL-02 cellswere obtained from the Institute of Biochemistry
andCell Biology. The cells were cultured inDulbecco’smodified
Eagle’s medium (DMEM, Gibco) containing 20 % fetal bovine
serum at 37 °C in 5 % CO2 incubator. IH exposure was con-
ducted using a custom-designed computer controlled incuba-
tor chamber connected to a BioSpherix OxyCycler
(BioSpherix, Redfield, NY, USA). Cells were maintained in
the hypoxic chamber in which O2 levels were alternated be-
tween 2 % for 5 min and 21 % for 10 min. Cells in the control
group were maintained in normoxic conditions (21 % O2 and
5 % CO2). In order to analyze the effect of oxygen concentra-
tions on the OSC expression, cells were maintained in the
cycle of 0 % O2 for 5 min and 21 % O2 for 10 min, cycle of
2 % O2 for 5 min and 21 % O2 for 10 min, cycle of 5 % O2 for
5 min and 21%O2 for 10min, and cycle of 10%O2 for 5 min
and 21 % O2 for 10 min or normoxia, respectively.
Cell growth assay
Cell Counting Kit-8 (CCK-8) assays were used to determine
cell proliferation according to the manufacturer’s instructions.
1×104 HL-02 cells were seeded in each pool of 96-well plates.
The cells were exposed to IH or normoxia for different time
intervals. After cultivation, CCK-8 reagents (WST-8) were
added to each well at different time points and then incubated
for 1.5 h at 37 °C in the absence of light. Then the WST-8 was
reduced to yellow formazan by the dehydrogenase in the
mitochondrial of living cells. The absorbance of dissolved
yellow formazan was measured at a test wavelength of
450 nm and a reference wavelength of 630 nm with a micro-
plate reader (Bio-Rad).
Cell apoptosis assay
HL-02 cells were plated in six-well plates and incubated for
24 h. Then the cells were exposed to IH or normoxia for
4 days. After IH treatment, cells were harvested by
trypsinization and washed twice in phosphate buffer saline
(PBS) . When the ce l l s undergo apoptos i s , t he
phosphatidylserine inverts from the inner membrane surface
to the outer membrane surface and binds with fluorescein
isothiocyanate (FITC)-labeled annexin V. After staining with
the combination of annexin V/FITC and propidium iodide
(PI) (annexin V-FITC apoptosis detection kit, BD
Pharmingen), the cells were immediately analyzed by flow
cytometry (FACSCalibur, Becton Dickinson).
Real-time PCR
Total ribonucleic acid (RNA) was extracted from treated HL-
02 cells using Trizol reagent according to the manufacturer’s
instructions. The complementary deoxyribonucleic acid
(cDNA) was synthesized from total RNA as template using
a high-capacity cDNA reverse transcription kit (Takara, Japan).
Real-time PCR was performed using Fast SYBR® Green
Master Mix (Applied Biosystems). The PCR primers for OSC
were as follows: 5′-TGCAGAATCAGTGTCCGTCC-3′, 5′-
TAGGTATGCCCCA TGCAAGC-3′. The messenger RNA
(mRNA) signal was normalized to β-actin signal.
Western blot analysis
After IH treatment, cells were lysed with a solution containing
Tris-HCl (50 mmol/L, pH 6.8), sodium dodecyl sulfonate
(SDS) (2 % w/v), glycerol (10 %), and dithiothreitol
(10 mmol/L), supplemented with protease inhibitor mix
(Thermo Fisher). Cell lysates were centrifuged at 12,000×g
for 30 min. Equal amounts of the protein (50 μg) were re-
solved by sodium dodecyl sulfonate-polyacrylamide gel elec-
trophoresis (SDS-PAGE) and transferred onto nitrocellulose
membranes. The membranes were blocked with 5 % non-fat
dry milk in Tris buffered saline (TBS) for 1 h at room temper-
ature and then incubated with primary antibodies against
OSC, hypoxia-inducible factor-1 (HIF-1), SREBP-1, fatty ac-
id synthase (FAS), or β-actin at 4 °C overnight. Membranes
were washed and treated with appropriate secondary antibod-
ies for 1 h at room temperature. The immunocomplexes were
detected with the enhanced chemiluminescence plus kit.
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Plasmid constructs
The OSC cDNA clone was cloned from the cDNA of HepG2
cell line, performed by polymerase chain reaction (PCR) then
inserted coding sequence in the pEGFP-N1 plasmid
(Invitrogen). The EGFP tag sequence was fused to the C-
terminus of the proteins to facilitate further detection via con-
focal microscope. The plasmids were obtained using the Plas-
mid Maxiprep kit (Vigorous) and verified by DNA
sequencing.
Oil red staining
The HL-02 cells were cultivated on glass cover slides. Af-
ter cultivation for 24 h, cells reached 90 % confluence and
transfection was performed. The cells were transfected
with plasmids pEGFP-N1 or oxidosqualene cyclase-
enhanced green fluorescence protein (OSC-EGFP) using
Lipofectamine 2000 (Invitrogen) following the instruc-
tions. After transfection for 4 h, the cells were moved to
a fresh high glucose DMEM medium to remove the trans-
fection reagent. After 24 h cultivation, the transfected cells
were exposed to IH or normoxia for 4 days. After treat-
ment, cells were fixed by 4 % paraformaldehyde for 40 min
followed by washing with PBS for three times, then stained
with oil red. The nuclei were counterstained with DAPI.
The mounted cells were visualized using a Carl Zeiss LSM
710 confocal microscope.
TG level assay
The HL-02 cells were seeded in six-well plates and transfected
with pEGFP-N1 or OSC-EGFP. After 24 h transfection, cells
were exposed to IH or normoxia for 4 days. After treatment,
cells were harvested. Lipids were assayed by a Triglyceride
Quantification Kit from Cayman Chemical according to the
manufacturer’s instructions. The total protein level was used
as normalization.
Statistical analysis
In our study, all of the experiments were conducted three times
with consistent results. The data of representative experiments
are presented. In the bar figures, a mean value and standard
error of multiple data points or samples were used to represent
the final result. Student’s t test or one-way ANOVAwas used
in statistical analysis of the data with significance p<0.05.
Results
IH inhibited cell proliferation and accelerated cell
apoptosis
As compared with exposure to normoxia, HL-02 cells treated
with IH had reduced cell proliferation as assessed by the
CCK-8 assay (Fig. 1a). As compared with exposure to
Fig. 1 Intermittent hypoxia (IH)
was toxic for HL-02 cells and
inhibited their proliferation. HL-
02 cells were exposed to IH (cycle
of 5 min 2 % O2 and 10 min 21 %
O2) or normoxia (21 % O2) for
4 days. a Effect of the IH on HL-
02 cell viability. A total of 104
cells were seeded in each pool of
96-well plates, and then cell
viability was assayed using CCK-
8 after treatment. b
Representative flow cytometry
profiles of cell apoptosis probed
by annexin V binding
(horizontal) and PI exclusion
(vertical). c Percentages of
apoptotic HL-02 cells after IH
treatment. *p<0.05 vs the cells
grown under normoxic conditions
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normoxia, HL-02 cells treated with IH for 4 days had in-
creased proportions of apoptotic cells (Fig. 1b, c).
IH decreased OSC expression in a dose-dependent
manner
As shown in Fig. 2a, the mRNA level of OSC was significant-
ly decreased in HL-02 cells treated with IH at different oxygen
concentrations for 4 days. Western analysis also showed that
protein level of OSC was decreased in HL-02 cells treated
with IH at different oxygen concentrations for 4 days
(Fig. 2b).
IH decreased OSC expression in a time-dependent
manner
As compared with exposure to normoxia, HL-02 cells treated
with IH resulted in a decrease of OSC mRNA in a time-
dependent manner (Fig. 3a). Western analysis also showed
that the protein level of OSC was decreased in HL-02 cells
treated with IH at different time points (Fig. 3b).
Over-expression of OSC enhanced proliferation
and decreased apoptosis in HL-02 cells treated with IH
As shown in Fig. 4a, the cells transfected with OSC-EGFP
had enhanced expression of OSC compared with the cells
transfected with pEGFP-N1 control plasmid. OSC protein in-
creased about twofold in the cells transfected with OSC-EGFP
as compared with that in the cells transfected with pEGFP-N1.
The result of CCK-8 assay showed that the over-expression
of OSC attenuated IH-induced proliferation inhibition in HL-
02 cells (Fig. 4b). Apoptosis analysis also showed that over-
expression of OSC resulted in the decrease of apoptotic cells
as compared with that in the pEGFP-N1-transfected HL-02
cells treated with IH (Fig. 4c, d).
Over-expression of OSC decreased TG content in HL-02
cells treated with IH
As compared with normoxia, Triglyceride (TG) content was
significantly increased after exposure to IH for 4 days in HL-
02 cells transfected with pEGFP-N1 control plasmid. Over-
expression of OSC did not influence the TG content in HL-02
cells under normoxic condition. However, over-expression of
OSC significantly decreased the TG content in HL-02 cells
treated with IH for 4 days (Fig. 5a, b).Moreover, we evaluated
the expression of HIF-1, SREBP-1, and FAS byWestern blot.
We found that IH increased the expression of HIF-1, SREBP-
1, and FAS. Over-expression of OSC attenuated the IH-
induced increase in the expression of HIF-1, SREBP-1, and
FAS (Fig. 5c).
Discussion
Clinical literature suggests that there is an association between
OSA and hepatic cell injury, and the severity is directly pro-
portional to the hypoxic stress of OSA [19–21]. Polotsky et al.
studied 90 consecutive patients who suffered from OSA and
reported that nocturnal oxygen desaturation might predispose
to hepatic inflammation, hepatocyte ballooning, and liver fi-
brosis [22]. The association between OSA and hepatic cell
injury has been further supported by animal experiments.
The findings in the present study extend these observations
by demonstrating that exposure of hepatic cells HL-02 to IH
led to a marked cell growth inhibition and elevation in cell
apoptosis.
Many studies have shown that IH results in hyperlipidemia
and IH-induced hyperlipidemia contribute to liver injury. IH
was associated with increased serum total cholesterol and tri-
glycerides. Similarly, an increase in liver lipid content was
noted [23–25]. Therefore, the expression profile of the genes
Fig. 2 Expression of OSC in HL-02 cells treated with IH (cycles of 0, 2,
5, or 10 % O2 5 min and 21 % O2 10 min) for 4 days. a mRNA levels of
OSC expression in HL-02 cells were determined with real-time
quantitative PCR under different oxygen concentrations. b Protein
levels of OSC expression in HL-02 cells were determined by Western
blot after IH treatment. *p<0.05, **p<0.01 vs the cells grown under
normoxic conditions
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involved in lipid metabolism was explored under IH condi-
tions. Studies showed that IH induces HIF-1 in the liver
which, in turn, activates SREBP-1. In concert, SREBP-1 in-
duces gene expression of SCD-1, independent of SREBP-2, to
enhance triglyceride and phospholipid biosynthesis [26]. In
this study, we evaluated the impact of hypoxia on the expres-
sion of OSC, an important enzyme of cholesterol biosynthesis,
in the human hepatic cell line HL-02.We demonstrated for the
first time that OSC mRNA, as well as protein, was decreased
under intermittent hypoxic conditions. In order to investigate
the role of OSC in the IH-induced apoptosis, OSC was over-
expressed in the HL-02 cells. We found that over-expression
of OSC could protect the IH-induced hepatic cell injury. To
further analyze the mechanism through which over-
expression of OSC protect the HL-02 cells against IH-
induced apoptosis, the lipid content in the cells was deter-
mined. The results showed that IH could induce the lipid
droplet accumulation and TG content, and over-expression
of OSC can prevent superabundance of the lipid droplet accu-
mulation and TG content in IH-treated HL-02 cells.
OSC catalyzes the conversion of the 2,3-oxidosqualene
into lanosterol in mammals [27]. OSC occupies a unique po-
sition in the cholesterol biosynthetic pathway. In fact, it cata-
lyzes not only the conversion of 2,3-monoepoxysqualene to
Fig. 3 Expression of OSC in HL-02 cells treated with IH (cycle of 2 %
O2 5 min and 21 % O2 10 min) for different times. a mRNA levels of
OSC expression in HL-02 cells were determined with real-time
quantitative RT-PCR in an IH treatment time course study. b Protein
levels of OSC expression in HL-02 cells were determined by Western
blot after IH treatment. *p<0.05, **p<0.01 vs the cells grown under
normoxic conditions
Fig. 4 Over-expression of OSC
can protect HL-02 cells from the
injury of IH. After transfection,
HL-02 cells were exposed to IH
(cycle of 2 % O2 5 min and 21 %
O2 10 min) or normoxia (21 %
O2) for 4 days. a Protein levels of
OSC in HL-02 cells transfected
with pEGFP-N1 or OSC-pEGFP
were determined by Western blot
after IH treatment. b Effect of the
IH on the cell viability in HL-02
cells transfected with pEGFP-N1
or OSC-PGFP. c Representative
flow cytometry profiles of cell
apoptosis probed by annexin V
binding (horizontal) and PI
exclusion (vertical) in HL-02
cells transfected with pEGFP-N1
or OSC-EGFP after IH treatment.
d Percentages of apoptotic HL-02
cells transfected with pEGFP-N1
or OSC-EGFP after IH treatment.
*p<0.05 vs the cells transfected
with pEGFP-N1 control plasmid
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lanosterol but also the cyclizat ion of 2,3;22,23-
diepoxysqualene to 24(S),25-epoxylanosterol which is subse-
quently transformed into 24(S),25-epoxycholesterol [28]. The
synthesis of 24(S),25-epoxycholesterol is favored over cho-
lesterol synthesis under condition of partial OSC inhibition.
24(S),25-epoxycholesterol is a potent activator of the liver X
receptor (LXR). LXR activation is known to increase tran-
scription of a number of genes important in the regulation of
hepatic lipid metabolism, including SREBP-1 and fatty acid
synthase [29]. In our study, we found that IH increased the
expression of HIF-1, SREBP-1, and FAS. OSC could inhibit
the IH-induced expression of HIF-1, SREBP-1, and FAS.
Therefore, IH-mediated inhibition of OSC may increase the
synthesis of 24(S),25-epoxycholesterol and result in the syn-
thesis and accumulation of hepatic triglycerides through HIF-
1, SREBP-1, and FAS activation. Increased accumulation of
triglycerides predisposes HL-02 cells to apoptosis. In addition,
a recent study reports that OSC protected self-renewing T2EC
cells from apoptosis and blocked their differentiation program.
This study indicated that OSC itself or the product of this
enzyme may play a part in apoptosis process [30].
In conclusion, the expression of OSC was inhibited under
hypoxic conditions. Over-expression of OSC could protect
HL-02 cells against hypoxia-induced apoptosis. The mecha-
nism underlying the protective effect of OSC on the IH-
induced apoptosis may be that over-expression of OSC could
inhibit the accumulation of TG in the HL-02 cells.
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